Specialty Pharmaceutical Company with a Focus in Pain and Addiction

Filing date Description Form Filing Group Filer View

Quarterly report which provides a continuing view of a company's financial position

10-Q
Quarterly Filings
0001193125-18-244507.pdf 0001193125-18-244507.rtf 0001193125-18-244507.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

An amendment to a SC 13D filing

SC 13D/A
3,4,5
0000921895-18-002225.pdf 0000921895-18-002225.rtf 0000921895-18-002225.xls View HTML

An amendment to a 3 filing. Non-EDGAR filing

3/A
3,4,5
Broadfin Capita 0000899243-18-021566.pdf 0000899243-18-021566.rtf View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-18-239740.pdf 0001193125-18-239740.rtf 0001193125-18-239740.xls View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Watson W. Mark 0000899243-18-021411.pdf 0000899243-18-021411.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Davis Todd C 0000899243-18-021412.pdf 0000899243-18-021412.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Greenleaf Peter 0000899243-18-021409.pdf 0000899243-18-021409.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Broadfin Capita 0000899243-18-021408.pdf 0000899243-18-021408.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Smith Thomas B 0000899243-18-021008.pdf 0000899243-18-021008.rtf View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Smith Thomas B 0000899243-18-021006.pdf 0000899243-18-021006.rtf View HTML

Copyright Morningstar